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The fat-soluble vitamin K (VK) has long been known as a requirement for blood
coagulation, but like other vitamins, has been recently recognized to play further
physiological roles, particularly in cell development and homeostasis. Vertebrates cannot
de novo synthesize VK, which is essential, and it can only be obtained from the
diet or by the activity of the gut microbiota. The IPEC-J2 cell line, obtained from
porcine small intestine, which shows strong similarities to the human one, represents
an excellent functional model to in vitro study the effect of compounds at the intestinal
level. The acute VK treatments on the bioenergetic features of IPEC-J2 cells were
evaluated by Seahorse XP Agilent technology. VK exists in different structurally related
forms (vitamers), all featured by a naphtoquinone moiety, but with distinct effects
on IPEC-J2 energy metabolism. The VK1, which has a long hydrocarbon chain, at
both concentrations (5 and 10 µM), increases the cellular ATP production due to
oxidative phosphorylation (OXPHOS) by 5% and by 30% through glycolysis. The
VK2 at 5 µM only stimulates ATP production by OXPHOS. Conversely, 10 µM VK3,
which lacks the long side chain, inhibits OXPHOS by 30% and glycolysis by 45%.
However, even if IPEC-J2 cells mainly prefer OXPHOS to glycolysis to produce ATP,
the OXPHOS/glycolysis ratio significantly decreases in VK1-treated cells, is unaffected
by VK2, and only significantly increased by 10 µM VK3. VK1, at the two concentrations
tested, does not affect the mitochondrial bioenergetic parameters, while 5 µM VK2
increases and 5 µM VK3 reduces the mitochondrial respiration (i.e., maximal respiration
and spare respiratory capacity). Moreover, 10 µM VK3 impairs OXPHOS, as shown by
the increase in the proton leak, namely the proton backward entry to the matrix space,
thus pointing out mitochondrial toxicity. Furthermore, in the presence of both VK1 and
VK2 concentrations, the glycolytic parameters, namely the glycolytic capacity and the
glycolytic reserve, are unaltered. In contrast, the inhibition of glycoATP production by
VK3 is linked to the 80% inhibition of glycolysis, resulting in a reduced glycolytic capacity
and reserve. These data, which demonstrate the VK ability to differently modulate IPEC-
J2 cell energy metabolism according to the different structural features of the vitamers,
can mirror VK modulatory effects on the cell membrane features and, as a cascade, on
the epithelial cell properties and gut functions: balance of salt and water, macromolecule
cleavage, detoxification of harmful compounds, and nitrogen recycling.
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INTRODUCTION
Vitamin K (VK) was originally recognized as a component
in blood clotting, being a cofactor for vitamin K–dependent
carboxylase, which facilitates the post-translational modification
of glutamic acid to γ-carboxy-glutamic acid residues in selected
proteins (Suttie, 1985). The relevant recognized VK role in
coagulation, hence the symbol K, from the German term
“Koagulation,” promptly enrolled VK among micronutrients.
Even if partially provided by gut microbiota, VK requires
dietary uptake, even if the required amounts are still undefined.
The intestinal absorption of VKs follows the dietary lipid pattern
(Shearer et al., 2012).
The VK family consists of structurally similar
naphthoquinones (Figure 1), which, due to their lipophilicity,
can easily cross cell membranes. VK naturally exists in two
forms, namely, phylloquinone (VK1), which bears a phytyl side
chain, mainly comes from vegetables and constitutes more than
90% of dietary VKs, and menaquinones (VK2), which exist in
multiple structures, mainly come from bacterial synthesis in
the gut, and occur in fermented foods (Schwalfenberg, 2017).
The extent to which endogenous VK2 production contributes
to the daily VK requirement is still unknown (Shearer et al.,
2012). Accordingly, the VK2 form menaquinone-4 can be
synthesized from VK1, which is absorbed in the small intestine,
and represents the most abundant VK form in tissues (Okano
et al., 2008). The VK homologs are characterized by a 2-methyl-
1,4-naphthoquinone nucleus and a polyisoprenoid side chain at
the 3-position (Figure 1). In VK2 vitamers the side chain varies
FIGURE 1 | Structures of vitamin K vitamers. (A) Phylloquinone or Vitamin K1;
(B) Menaquinone-4 or Vitamin K2; (C) Menadione or Vitamin K3. The
2-methyl-1,4-naphthoquinone nucleus and the (poly)isoprenoid side chains
are highlighted in olive and red, respectively.
in both length and saturation degree (Tsugawa and Shiraki,
2020). The VK2 basic structure, which has a side chain with four
double bonds, is similar to Coenzyme Q10 (CoQ10), involved
as an electron carrier in mitochondrial respiration, but has a
shorter hydrophobic side chain whose four prenyl units confer
higher hydrophilicity. Finally, menadione, or VK3, lacks the
hydrocarbon side chain and is considered as a metabolite or a
provitamin (Schwalfenberg, 2017).
Over the last two decades, roles and action mechanisms of
VKs other than the involvement in γ-carboxylation, a post-
translational modification which modulates the function of
various proteins, have been discovered. Recently, VKs were found
to play a relevant role in extrahepatic metabolism, such as in bone
and blood vessels, in energy metabolism (Tsugawa and Shiraki,
2020), and in counteracting inflammation, as VK deficiency
has been associated with human diseases with inflammatory
background. Until very recently, VKs were considered capable
of playing a role against colorectal cancer and other cancer
types (Schwalfenberg, 2017) by inhibiting the cell proliferation,
including an active induction of the cell cycle arrest, and to
induce apoptosis in different human gastrointestinal cancer cells
(Orlando et al., 2015). VKs also improve cognitive function in
elderly patients and decrease the risk of diabetes (Schwalfenberg,
2017). At least some of these emerging roles may also be related
to the VK involvement in signaling as modulators of selected
nuclear receptors. Accordingly, VK2 (menaquinone-4) binds to
the transcription factor SXR/PXR, thus acting like a hormone
like other lipophilic vitamins. Therefore, its effects are widely
spread in body systems, and it is recognized to increase longevity
(Gordeladze, 2017). VK2 can also bind the 17β-Hydroxysteroid
dehydrogenase type 4 (17β-HSD4) and activate protein kinase A
(PKA), but the mechanisms of binding and enzyme regulation
remain unknown (Azuma and Inoue, 2019).
The CoQ10-like structure of VK2 has raised hopes to exploit
VK to treat some mitochondrial defects (Vos et al., 2012).
However, the possible replacement of CoQ10 by VK2 in the
respiratory chain, as well as the putative role of vitamins K3
and C to improve ATP production by reducing cytochrome c
through two coupled redox cycles (Ivanova et al., 2018), are still
a matter of debate. Unexpectedly, VK2 was a poorly efficient
respiratory substrate in human cells in vitro (Cerqua et al., 2019).
VK3 is potentially toxic and able to counteract some cancer types
(Schwalfenberg, 2017). Interestingly, VK3 affects the redox status
of thiols, can induce oxidative stress in cancer cells, and seems the
most efficient VK form in combination with vitamin C to restore
oxidative phosphorylation (Ivanova et al., 2018).
Up to now, VK involvement in the bioenergetics of
enterocytes, which are not only directly involved in VK
absorption but also are in proximity with gut microbiota which
provide VK2, has not been explored. The IPEC-J2 cell line
(Vergauwen, 2015), initially established in 1989 and obtained
from the small intestine of the pig, which shows anatomical
and physiological similarities to humans, has been selected as
in vitro model to investigate the action mechanisms at the
biochemical and molecular level of a variety of compounds
on mammalian intestine (Wu et al., 2019). Due to their
features, IPEC-J2 cells provide an excellent in vitro model to
Frontiers in Molecular Biosciences | www.frontiersin.org 2 May 2021 | Volume 8 | Article 682191
fmolb-08-682191 May 18, 2021 Time: 17:17 # 3
Bernardini et al. Effect of VKs on IPEC-J2 Cell Metabolism
investigate the effects of VKs on cell bioenergetics. This cell
line is neither transformed nor tumorigenic and reproduces the
human physiology features more closely than any other cell
line of non-human origin. Of note, this cell line guarantees the
reproducibility of the results since it maintains the differentiated
characteristics and exhibits strong similarities to primary cell
cultures. As far as we are aware, only a few studies approached
cell bioenergetics in this cell line under normal conditions
(Tan et al., 2015; Bernardini et al., 2021), highlighting that
these cells mirror the known behavior of intestinal cells, since
they preferentially derive energy from glucose plus glutamine
than from glucose alone. Enterocytes mainly use glycolysis to
provide metabolic precursors to the liver, while mitochondrial
respiration provides the main energy source (Nesci, 2017).
IPEC-J2, as well as IPEC-J1, have the typical differentiation
of an enterocyte, which is independent of the culture system.
The aerobic environment can start the initial proliferation and
sequential differentiation of intestinal epithelial cells and progeny
loss (Nossol et al., 2011). Enterocyte mitochondrial function
is important for gut permeability. Accordingly, mitochondrial
uncoupling increases intestinal permeability, generating local and
systemic inflammation, which is associated with the development
of inflammatory bowel diseases (Bórquez et al., 2020).
This study, which focuses on VK effects on IPEC-J2 cells,
aims at deepening the knowledge on the multiple VK roles and
on the responses of the energy machinery to these quinone
compounds. IPEC-J2 cells, which exhibit strong similarities to
primary intestinal epithelial cells, may address studies on the
most suitable VK form to modulate enterocyte bioenergetics.
Accordingly, structural differences among VK vitamers may be
relevant to produce different effects. Moreover, this study, by
providing clues on the putative modulatory role of VKs on cell




α-Phylloquinone (Vitamin K1), Menaquinone-4 (Vitamin K2),
and Menadione (Vitamin K3) were purchased from Cayman
Chemical. Seahorse XF Assay Kits and Reagents were purchased
from Agilent. All other chemicals were reagent grade and used
without purification. Quartz double-distilled water was used for
all reagent solutions, except when otherwise stated.
Cell Culture
The non-transformed cell line IPEC-J2 was purchased from the
“Deutsche Sammlung von Mikroorganismen und Zellkulturen
GmbH” (DSMZ). Cells were cultured in Dulbecco’s Modified
Eagle Medium (DMEM) (4.5 g/l glucose) added with 10%
of fetal bovine serum (FBS, Life Technologies) and 1×
antibiotic-antimycotic solution (Life Technologies) in a 5% CO2
atmosphere at 37◦C. Cultures were split weekly in T25 [0.5× 106
or T75 (1.5 × 106) culture flasks (Corning-Becton Dickinson
and Company Becton Drive, Franklin Lakes, NJ, United States).
For cryopreservation, 1.5 × 106 were resuspended in 1 ml of
freezing medium (DMEM added with 20% FBS, 1× antibiotic-
antimycotic solution, and 10% DMSO). The cryovials were placed
in a freezing box and stored at -80◦C overnight. For long-term
storage, the cryovials were transferred into a cryogenic biobank.
Cellular Bioenergetics
The Seahorse XFp analyzer (Agilent) was used to simultaneously
measure oxygen consumption rate (OCR), an index of cell
respiration (pmol/min), and extracellular acidification rate
(ECAR), an index of glycolysis (mpH/min). IPEC-J2 cells
(1 × 104 / well) were grown in XFp cell culture miniplates
(Agilent) for 24 h. On the experiment day, IPEC-J2 cells were
switched to freshly made Seahorse XF DMEM medium pH 7.4
supplemented with 10 mM glucose, 1 mM sodium pyruvate,
and 2 mM L-glutamine, in the absence (Control) and in the
presence of 5 or 10 µM of each VK vitamer (VK1, VK2 or
VK3) under study. The plates were incubated at 37◦C in air
for 45 m in before measuring OCR and ECAR by the adequate
programs (ATP Rate Assay, Cell Mito Stress Test and Cell Energy
Phenotype Test). The injection ports of XFp sensor cartridges,
which were hydrated overnight with XF calibrant at 37◦C, were
loaded with 10× concentration of inhibitors according to the
instructions provided by Seahorse XFp ATP Rate Assay, Cell
Mito Stress Test, and Cell Energy Phenotype Test. The final
concentration used for ATP Rate Assay were 1.5 µM oligomycin
(port A) and 0.5 µM rotenone (Rot) plus 0.5 µM antimycin A
(AA) (port B). For Cell Mito Stress Test the final concentrations
were 1.5 µM oligomycin (olig) (port A), 1.0 µM Carbonyl-
cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP) (port B),
and 0.5 µM rotenone plus antimycin A (port C), while for the
Cell Energy Phenotype Test the final concentrations were 1.5 µM
oligomycin plus 1.0 µM FCCP (port A). All the analysis were
run at 37◦C. All data were analyzed by WAVE software; OCR
and ECAR values were normalized to the total number of cells
per well. All parameter values were calculated per well, according
to the manufacturer’s instructions. Both ATP Rate Assay, Mito
Stress Test, and Cell Energy Phenotype Test were carried out
three times in independent experiments (Marcoccia et al., 2021).
The ATP Rate Assay provides the bioenergetic parameters
currently used to characterize the cellular ATP production,
namely ATP production rate, related to the conversion of
glucose to lactate in the glycolytic pathway (glycoATP Production
Rate) and to the mitochondrial OXPHOS (mitoATP Production
Rate). Accordingly, the ratio between mitoATP Production Rate
and glycoATP Production Rate (ATP Rate Index) is currently
considered as a valuable parameter to detect changes and/or
differences in the metabolic phenotype (a ratio >1 means mainly
OXPHOS pathway; a ratio <1 means mainly glycolytic pathway).
The Mito Stress Test enables the characterization of cell
respiration by the following parameters: basal respiration,
detected as baseline OCR before oligomycin addition; minimal
respiration measured as OCR in the presence of oligomycin;
and maximal respiration evaluated as OCR after FCCP addition.
The so-called proton leak, which corresponds to the difference
between the basal respiration and the respiration in the presence
of oligomycin (minimal respiration), indicates the re-entry of
H+ in the intermembrane space independently of the F1FO-ATP
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synthase. The non-mitochondrial respiration, evaluated as OCR
in the presence of rotenone plus antimycin A (respiratory chain
inhibitors), was subtracted from all the above parameters. The
ATP turnover or oligomycin-sensitive respiration was obtained
from the difference between the basal respiration and the
minimal respiration (OCR in presence of oligomycin). Finally,
the difference between the maximal and the basal respiration
provided the spare capacity, which represents the ability to
respond to an increased energy demand and can be considered
as a measure of the flexibility of the OXPHOS machinery
(Bernardini et al., 2021).
The simultaneous measurement of mitochondrial respiration
and glycolysis was carried out by the Cell Energy Phenotype
Test under baseline and stressed conditions, the latter after
simultaneous addition of oligomycin and FCCP. Oligomycin
inhibits the mitochondrial ATP production by the F1FO-
ATP synthase and the cell compensates the failed OXPHOS
by increasing the glycolysis rate, while the dissipation of
the electrochemical gradient of H+ in mitochondria by the
ionophore FCCP drives the highest oxygen consumption
(uncoupled respiration). The assay allows to evaluate two main
parameters of cell energy metabolism, known as metabolic
phenotypes (baseline and stressed phenotype) and metabolic
potential. The baseline phenotype is featured by the OCR and
ECAR values in cells under the starting condition in the presence
of substrates. The stressed phenotype is shown by the OCR
and ECAR values in cells after addition of stressor compounds
(oligomycin plus FCCP). The metabolic potential is the ability to
increase energy production via respiration and glycolysis and it
is defined as the % increase of stressed phenotype over baseline
phenotype of OCR and ECAR (Bernardini et al., 2021).
Statistical Analysis
Statistical analyses were performed by SIGMASTAT software.
Each treatment was replicated three or eight times (viability test)
in three independent experiments. Data were analyzed by
the Student’s t-test, or by one-way analysis of variance
(ANOVA) followed by Students–Newman–Keuls test when F
values indicated significance (P ≤ 0.05) was applied. Percentage




The cellular ATP level produced by OXPHOS and glycolysis
in the presence of the different VK vitamers are shown in
Figure 2 by OCR and ECAR values, respectively, under basal
metabolic conditions. The calculation of the mitoATP and
glycoATP production rate (Figure 2), obtained by injecting
oligomycin to inhibit mitochondrial ATP synthesis and then
rotenone plus antimycin A to block mitochondrial respiration,
highlight that IPEC-J2 cells are characterized by an oxidative
metabolism. VK1 induces an increase in total ATP production
at both the concentrations tested (5 and 10 µM). This increase
is due to a significant glycoATP production activation, whereas
the mitoATP production is unaffected (Figure 2A). Conversely,
VK2 does not affect the glycoATP production. The total ATP
production is only 20% increased by 5 µM VK2 with respect to
the control, due to an enhanced mitochondrial ATP synthesis
(Figure 2B). VK3 shows a concentration-dependent effect on
intracellular ATP production by increasing the glycolysis by
30%without modifying the mitochondrial activity at 5 µM,
whereas at 10 µM it reduces by 50% the glycoATP and the
mitoATP synthesis by 30% (Figure 2C). Even if all the VK
vitamers can modify ATP production, the results highlight that
the ratio between mitoATP Production Rate and glycoATP
Production Rate (ATP Rate Index) is always > 1. In detail, 5
and 10 µM VK1 decrease the propensity to produce mitoATP
with respect to the control (Figure 2D), whereas this effect
is not shown by VK2 which does not modify the ATP rate
index (Figure 2E). In IPEC-J2 cells treated with 10 µMVK3,
the residual ATP production mainly relies on mitochondrial
oxidative metabolism (Figure 2F).
Cellular Respiration
The profile and function of cell respiration of IPEC-J2 cells
treated with VKs are shown in Figure 3. The key parameters of
cell metabolism were obtained from functional metabolic data as
detailed in the Materials and mMethods section. The results show
that OCR values in the presence of both VK1 concentrations
tested are not different from control ones (Figures 3A,B).
VK1 does not modify the basal respiration and the proton
leak; consequently, the calculated ATP turnover is not affected.
Therefore, the coupling efficiency in the presence and in the
absence of VK1 is about 0.80 a.u. (the maximal value of
1.0 a.u. is obtained when all the basal respiration is sensitive
to oligomycin). The IPEC-J2 OCR in the presence of FCCP
(maximal respiration) shows a twice higher value than basal
OCR. The spare respiratory capacity, which defines the cell
propensity to adjust cell bioenergetics to fulfill the increased
energy demand, constantly attains a 50% OCR value of the FCCP-
stimulated OCR, irrespective of the VK1 presence (Figure 3B).
VK2 has a concentration-dependent effect on the OCR
(Figure 3C). Accordingly, 5 µM VK2 increases the basal,
maximal, and spare capacity OCR, as well as ATP turnover with
respect to the control. Conversely, at 10 µM VK2 the effect
on the same parameters is inhibitory (Figure 3D). Even if the
basal and ATP turnover is higher in presence of 5 µM VK2 and
lower at 10 µM VK2, with respect to the control, the coupling
efficiencies values in the presence of VK2 (0.77 a.u.) are not
different from those of the control. Likewise, on comparing
the maximal respiration and the spare respiratory capacity in
the absence or in the presence of the two VK2 concentrations,
significantly different OCR values are shown. However, the OCR
values of the maximal respiration and spare respiratory capacity
in all treatments (0.0, 5.0, and 10 µM VK2) are of the same extent.
In detail, the maximal respiration is always twice higher than
the basal respiration, whereas for the latter the OCR activity is
increased by 50% with FCCP (Figure 3D).
As shown in Figure 3E, the respiratory profile of IPEC-J2
cells decreases with increasing VK3 concentrations. Even if the
basal respiration is apparently unaffected by VK3 (Figure 3F),
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FIGURE 2 | Effect of VKs on the real-time ATP production rate in IPEC-J2 cells. Evaluation of ATP production rate by mitochondrial OXPHOS (blue) () or by
glycolysis (red) () in VK1 (A), VK2 (B), and VK3 (C)-treated cells. The ATP rate index, calculated as the ratio between the mitochondrial ATP production rate and the
glycolytic ATP production rate, is shown on the y-axis (logarithmic scale) in IPEC-J2 treated with 0 (Control), 5, and 10 µM VK1 (D), VK2 (E), and VK3 (F). Data,
expressed as column chart [(A,B,C) plots] and points [(D,E,F) plots], represent the mean ± SD (vertical bars) from three experiments carried out on distinct cell
preparations. Different lower-case letters indicate significantly different values (P ≤ 0.05) among treatments (0, 5, 10 µM) in the same metabolic pathway; different
upper-case letters indicate different values (P ≤ 0.05) among treatments in ATP production rates due to sum of OXPHOS plus glycolysis.
the coupling efficiency is halved by 10 µM VK3 as a result of an
increase in proton leak. In addition, IPEC-J2 cells treated with
5 µM VK3 do not show any respiration stimulation by FCCP,
while when these cells are treated with 10 µM VK3, not only
do they not show any increase in OCR in response to FCCP, but
also the OCR after FCCP addition is lower than the basal OCR.
Consistently, a strong inhibition of respiration with strongly
decreased or even abolished spare respiratory capacity is detected
in the presence of 5 and 10 µM VK3, respectively.
Extracellular Acidification
The glycolytic function in IPEC-J2 cells evaluated as extracellular
acidification rate (ECAR) does not show any change in the
presence of the two VK1 concentrations tested (Figure 4A). The
key parameters of glycolytic flux, i.e., Glycolysis and Glycolytic
Capacity, attain the same value in the presence or in the absence
of 5 µM VK. Conversely, 10 µM VK1 inhibits both parameters
by 15% (Figure 4B). However, the Glycolytic Reserve, defined
as the difference between Glycolytic Capacity and Glycolysis,
is unaffected by 10 µM VK1, since the two parameters show
a proportional decrease in ECAR with respect to the control
(Figure 3B).
Also, VK2 does not substantially modify the glycolytic profile
of IPEC-J2 cells (Figure 4C), but in this case the glycolytic reserve
disappears, since the Glycolysis rate has the same ECAR value as
the Glycolytic Capacity (Figure 4D).
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FIGURE 3 | Effect of VKs on the mitochondrial respiration profile in IPEC-J2 cells. Oxygen consumption rate (OCR) at two concentrations (5 and 10 µM) of VK1 (A),
VK2 (C), and VK3 (E) under basal respiration conditions and after the addition of 1.5 µM oligomycin (olig), 1.0 µM FCCP and a mixture of 0.5 µM rotenone plus
antimycin A (rot+AA). Inhibitor injections are shown as dotted lines. Mitochondrial parameters (basal respiration, ATP production, proton leak, maximal respiration,
spare respiratory capacity, non-mitochondrial oxygen consumption, ATP turnover) in VK absence (blue) () or in the presence of 5 µM (orange) (), or 10 µM (gray)
() VK1 (B), VK2 (D), and VK3 (F). Data expressed as points (A,C,E) and column chart (B,D,F) represent the mean ± SD (vertical bars) from three experiments
carried out on different cell preparations. Different letters indicate significant differences (P ≤ 0.05) among treatments within the same parameter.
VK3 shows an inhibitory action on ECAR with a
concentration-dependent effect (Figure 4E). The Glycolysis
and the Glycolytic Capacity are inhibited by 50 and 13% with 5
and 10 µM VK3, respectively. Conversely, the decrease in the
Glycolytic Reserve is independent of the VK3 concentration
tested (Figure 4F).
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FIGURE 4 | Effect of VKs on the glycolytic function in IPEC-J2 cells. Extracellular acidification rate (ECAR) at two concentrations (5 and 10 µM) of VK1 (A), VK2 (C),
and VK3 (E) under basal conditions and after the addition of 10 mM glucose, 5 µM oligomycin (olig), and 50 mM 2-DG. Injections are shown as dotted lines. The
three parameters of the glycolytic function: (glycolysis, glycolytic capacity, and glycolytic reserve) in VK absence (blue) (), or in the presence of 5 µM (orange) (), or
10 µM (gray) () VK1 (B), VK2 (D), and VK3 (F). Data expressed as points (A,C,E) and column chart (B,D,F) represent the mean ± SD (vertical bars) from three
experiments carried out on different cell preparations. Different letters indicate significant differences (P ≤ 0.05) among treatments within the same parameter.
Bioenergetic Phenogram
The cell energy production of IPEC-J2 cells detected by
OCR and ECAR in the presence or in the absence of VKs
is shown as metabolic phenotype under normal (baseline)
and stressed conditions (Figure 5). The treatment with
oligomycin and FCCP mixture, known as mitochondrial
stressors, provides the phenogram which illustrates the relative
baseline and stressed phenotype, and the response of the
metabolic potential (expressed as % baseline) of IPEC-J2 cells
after treatment with VKs.
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FIGURE 5 | Effect of VKs on the energy map of IPEC-J2 cells. Baseline (empty squares) and stressed (full squares) phenotypes of IPEC-J2 cells in VK absence
(control, blue squares) and in the presence of 5 µM, orange squares) or 10 µM (gray squares) VK1 (A), VK2 (C), and VK3 (E). The Metabolic potential in “Stressed
OCR” and “Stressed ECAR” is expressed as % “Baseline OCR” and “Baseline ECAR” (dashed horizontal line), in VK absence (blue) () or in the presence of 5 µM
(orange) (), or 10 µM (gray) () VK1 (B), VK2 (D), and VK3 (F). Data expressed as points (A,C,E) and column chart (B,D,F) represent the mean ± SD (vertical and
where present also horizontal bars) from three experiments carried out on distinct cell preparations. Different letters indicate significant differences (P ≤ 0.05) among
treatments within the same parameter.
According to the method adopted, the metabolic potential
indicates the cell’s ability to meet an energy demand by
mitochondrial respiration and glycolysis.
Irrespective of the presence of VK1, IPEC-J2 cells show
an increase in the utilization of both pathways (mitochondrial
respiration and glycolysis) (Figure 5A) under stressed conditions
without any significant difference in the metabolic potential in
the presence or absence of VK1 (Figure 5B).
The IPEC-J2 phenogram under starting assay conditions
(baseline phenotype) in the presence of substrates and without
stressors (oligomycin plus FCCP) do not show any difference
in the metabolic pathways between control and VK2 treated
cells. The same results are detected under stressed conditions
irrespective of the presence of VK2, even if in this case the
cells undergo a metabolic switch toward an energetic phenotype
(Figure 5C). The cell energy demand is satisfied by an increase
in OCR. The metabolic potential primarily relies on an efficient
mitochondrial energy metabolism. No difference in OCR values
between the VK2-treated IPEC-J2 cells and the control under
stressed conditions is detectable (Figure 4D). The two VK2
concentrations tested do not modify the glycolytic activity
stimulated by stressor compounds with respect to the control,
even if the stressed ECAR, expressed as metabolic potential, in
5 µM VK2-treated IPEC-J2 cells is lower than that in 10 µM
VK2-treated cells (Figure 5D).
VK3 affects the IPEC-J2 cells’ energy production, highlighting
an energy map which shows an inhibited aerobic metabolism
(Figure 5E). Stressed OCR and ECAR in the 5 µM VK3-treated
IPEC-J2cells are inhibited by 23 and 16%, respectively. The
treatment with 10 µM K3 makes IPEC-J2 cells shift their energy
production mode from OXPHOS to glycolysis (Figure 5F). In
these cells the stressed OCR is 11% lower than baseline OCR,
whereas the metabolic potential of glycolysis (ECAR) increases
by 50% when compared to baseline metabolism (Figure 5F).
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However, the baseline OCR/ECAR ratio in VK3-treated IPEC-
J2 cells is > 4. This means that, other than acidification from
glycolysis, the ECAR values in VK3-treated IPEC-J2 cells include
the contribution of the mitochondrial acidification by CO2
production by Krebs cycle. Accordingly, in aqueous media CO2
forms the weak acid H2CO3.
DISCUSSION
As far as we are aware, up to now the effect of the three VK
vitamers on the bioenergetic metabolism of enterocytes has been
poorly investigated. The IPEC-J2 cell line provides an excellent
model to evaluate in detail the mechanism(s) involved in cell
energy production. These cells also represent a good translational
model to study fat-soluble vitamin effects on cellular metabolism
in the gut. IPEC-J2 cells rely on oxidative metabolisms to supply
the energy required by the physiological functions (Vaugelade
et al., 1994; Bernardini et al., 2021).
The enhancement of ATP production by IPEC-J2 cells is
the most relevant bioenergetic effect of VK1, which primarily
contributes to stimulate the glycolytic pathway at both the
concentrations tested. Indeed, the modification of ATP rate index
highlights that VK1-treated IPEC-J2 cells switch to a less aerobic
metabolism, namely glycolysis vs OXPHOS, with respect to the
control, but without affecting the mitochondrial respiration and
the glycolysis parameters. The ATP production of VK2-treated
IPEC-J2 cells is only increased at the lower VK2 concentration
tested, namely 5 µM VK2. Indeed, the effect is corroborated
by the Mito Stress Test which shows that the mitochondrial
parameters are improved at 5 µM VK2 concentration tested.
The VK2 structure resembles that of the CoQ10, a membrane-
embedded electron carrier of mitochondrial electron transfer
system (mETS) (Lenaz et al., 1999), even if it cannot substitute
CoQ10 (Cerqua et al., 2019). VK2 can mimic the two structural
components of CoQ10 which are crucial in OXPHOS, namely
in the naphthoquinone core, which transfer electrons during the
redox-cycle, and in the isoprenoid tail, which allows diffusion
into the lipid bilayer. Recently both VK1 and VK2 were found to
decrease the order and to increase fluidity in model membranes
(Ausili et al., 2020). Therefore, these VKs may also act indirectly
by facilitating the function of respiratory complexes through the
inner mitochondrial membrane.
Short-chain quinones are known to be toxic, especially those
containing 0–3 isoprene units, whereas CoQ4 displays only
minimal toxicity (Takahashi et al., 2018). During mitochondrial
respiration the VK2 might transfer electrons from complex I or
complex II directly or indirectly to cytochrome c, according to
the diffusion mode of shuttling electrons along the respiratory
chain (Nesci and Lenaz, 2021). This VK2 role as electron
transporter in the respiratory chain (Colpa-Boonstra and Slater,
1958) is still controversial. Accordingly, in spite of reports
which rule out this possibility (Cerqua et al., 2019), in an
in vitro model VK2 enhanced respiratory chain efficiency
and contributed to building the electrochemical proton
gradient (1µH+) by respiratory complexes that are exploited
to generate ATP, similarly to CoQ10 (Vos et al., 2012). Our
findings show that the effect on mitochondrial respiration
could depend on VK2 concentration, namely the positive
effect shown at 5 µM VK2 may become harmful at high
concentrations. The VK2 structural properties are consistent
with the stimulation of mitochondrial respiration without any
effect on glycolysis. Consistently, low VK2 concentrations
can favor an energy boost in IPEC-J2 cell activation,
proliferation, and differentiation by increasing the OXPHOS
capability to produce ATP.
Vitamer VK3 is the only one of the three forms of VK under
study which exerts a negative effect on energy metabolism of
IPEC-J2 cells. Accordingly, cell respiration is inhibited by both
VK3 concentrations. The VK3-driven increase in H+ leakage
through the inner mitochondrial membrane leads to the decrease
in the ATP synthesis. However, uncoupling agents such as FCCP
can stimulate the mitochondrial respiration of VK3-reated IPEC-
J2 cells. The increase in non-phosphorylating substrate oxidation
is typical of a decrease in 1µH+, accompanied by production
of reactive oxygen species and increase in oxygen consumption
(Zorov et al., 2020). Conversely, we also detected in VK3-
treated IPEC-J2 cells an inhibited mitochondrial respiration, as
it happens in the presence of excess of uncouplers. Moreover,
the negative effect on cell metabolism is underscored by VK3-
driven enhancement of the ECAR-insensitive glycolytic activity
in IPEC-J2 cells. However, VK3-treated IPEC-J2 cells can only
rely on the glycolytic pathway to supply the energy required when
their energy production mode shifts upon induction of signaling
pathways of stress (Hung and Calkins, 2016).
The present study points out that the different VK vitamers
tested promote different effects on IPEC-J2 cell bioenergetics.
Accordingly, the chemical structure of the sidechain of VKs is
confirmed to be crucial to produce the effects.
New roles for VKs in reducing risk of certain chronic
diseases have been proposed in the last decades (Shearer et al.,
2012). Consistently, the present work which shows for the first
time how different VK forms and concentrations differently
act on the bioenergetics of IPEC-J2 cell line contributes
to deepening the knowledge on the varied roles of VKs
in enterocytes, of which the IPEC-J2 cell line constitutes
a fascinating model. The swine is increasingly used in
translational research and drug development (Monticello and
Haschek, 2016). Therefore, the benefits of a VK stimulation
of ATP production in enterocytes underlines and confirms the
relevance of gut microbiota, as VK producer, in maintaining
a healthy gut and, as a cascade, in the prevention and/or
treatment of diseases of the intestinal tract. Interestingly,
since the last century (Krasinski et al., 1985) certain chronic
gastrointestinal disorders were associated with VK deficiency.
At present this connection is established with Crohn’s disease
(Schoon et al., 2001), celiac disease (Djuric et al., 2007), and
inflammatory bowel disease (Nowak et al., 2014). Pathological
conditions are often associated with impaired mitochondrial
bioenergetics (Nesci et al., 2021). Moreover, VK antagonists
used in clinical therapy to prevent thromboembolism together
with coadministration of other drugs can induce drug-drug
interaction effects with VK malabsorption (Takada et al., 2015).
Infants cannot obtain VK from the breast milk and have poor
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intestinal adsorption due to immature glut flora. Therefore,
VK oral administration is the best way to prevent Vitamin K
deficiency bleeding in infancy (Araki and Shirahata, 2020). It
seems likely to postulate that an insufficient ATP production
by enterocytes, related to a poor VK availability, also due to
antibiotic treatments (Shirakawa et al., 1990), may represent, or
contribute to, the biochemical bases of some gut pathologies.
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